l carnitine for elevated ammonia Quantitative systems pharmacology Model to characterize valproic acid-induced hyperammonemia and the effect of L- carnitine supplementation Role of carnitine in disease – Reversible weakness and encephalopathy while
Reversible weakness and encephalopathy while on long term valproate treatment due to carnitine deficiency BMJ Case Reports Propionic Acidemia New England Consortium of Metabolic Programs Valproic Acid Induced Hyperammonemic Encephalopathy in a Patient with Bipolar Disorder: A Case Report Consensus guidelines for management of hyperammonaemia in paediatric patients receiving continuous kidney replacement therapy Nature Reviews Nephrology
Pay in 4 interest-free payments of $6.47 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7



